美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=TOFRANIL
符合检索条件的记录共8
1 页 当前第 1 页  返回检索页
1药品名称TOFRANIL
申请号011838产品号002
活性成分IMIPRAMINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格12.5MG/ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构NOVARTIS PHARMACEUTICALS CORP
2药品名称TOFRANIL-PM
申请号017090产品号001
活性成分IMIPRAMINE PAMOATE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 75MG HCL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构MALLINCKRODT INC
3药品名称TOFRANIL-PM
申请号017090产品号002
活性成分IMIPRAMINE PAMOATE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 150MG HCL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构MALLINCKRODT INC
4药品名称TOFRANIL-PM
申请号017090产品号003
活性成分IMIPRAMINE PAMOATE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 125MG HCL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构MALLINCKRODT INC
5药品名称TOFRANIL-PM
申请号017090产品号004
活性成分IMIPRAMINE PAMOATE市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 100MG HCL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构MALLINCKRODT INC
6药品名称TOFRANIL
申请号087844产品号001
活性成分IMIPRAMINE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;ORAL规格10MG
治疗等效代码AB参比药物
批准日期1984/05/22申请机构MALLINCKRODT INC
7药品名称TOFRANIL
申请号087845产品号001
活性成分IMIPRAMINE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;ORAL规格25MG
治疗等效代码AB参比药物
批准日期1984/05/22申请机构MALLINCKRODT INC
8药品名称TOFRANIL
申请号087846产品号001
活性成分IMIPRAMINE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET;ORAL规格50MG
治疗等效代码AB参比药物
批准日期1984/05/22申请机构MALLINCKRODT INC